Obesity is a well-known risk factor for type 2 diabetes. Now, a large new study adds to evidence that it also contributes to the much less common type 1 diabetes. The study, of nearly 1.5 million Israeli teenagers, found that those who were obese were twice as likely to develop type 1 diabetes by young… read on > read on >
Patients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease. Now, a new investigation may have landed on a surprising solution — a dummy pill that contains no medication of any kind. “Cancer-related fatigue is the most frequent and debilitating… read on > read on >
A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be as effective as weight-loss surgery. “About nine of 10 people in the study… read on > read on >
A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimab — an anti-PD-1 monoclonal antibody — every three weeks for six months… read on > read on >
MONDAY, June 6, 2022 (American Heart Association News) — Brian Kennedy was living his dream. A piano prodigy, he moved from his hometown of Kansas City, Missouri, to Los Angeles in 2003, when he was 20. He started out as a musician for hire, playing a handful of instruments and composing on his own. Then,… read on > read on >
Two “smart bomb” drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show. Both medications are antibody-drug conjugates, consisting of a chemo drug that’s been wedded to an antibody that delivers the chemotherapy directly to cancer cells. “That’s a way to take the chemo right to the cancer… read on > read on >
Diabetes increases the odds that a COVID-19 infection will be severe, and folks with diabetes may be up to four times more likely to develop long-lasting symptoms, new research suggests. “Though more data is needed, some early studies suggest that diabetes may be a risk factor for long COVID, and thus careful monitoring of people… read on > read on >
New research points to a compelling interplay between inflammatory bowel disease (IBD) and depression. IBD includes Crohn’s disease and ulcerative colitis. In addition to the physical pain that these illnesses can inflict upon sufferers, the new study showed that patients face a significantly increased risk of depression. Interestingly, the investigators also found that IBD-free siblings… read on > read on >
Here’s a simple weapon to employ against the opioid epidemic: New research finds that placing time limits on prescriptions for highly addictive narcotic painkillers may reduce the risk of misuse. In 2019, 1% of opioid prescriptions from U.S. dentists and surgeons were filled more than 30 days after being issued, long after the acute pain… read on > read on >
Holocaust survivors have a lower risk of delirium after surgery than others their age, and a new study suggests it may owe to mental resilience developed in response to their horrific experiences. “Given that Holocaust survivors are at increased risk of a range of physical and psychological conditions, we were surprised to find that they… read on > read on >
